ArticleValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research2017
Evaluating Frameworks That Provide Value Measures for Health Care Interventions.
Article in Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 4 syntheses or guidelines pooled it, 60 citations in OpenAlex.
- Factors Influencing the Implementation and Adoption of Digital Nursing Technologies: Systematic Umbrella Review.Journal of medical Internet research · 2025Pooled it
- Systematic Review of the Cost Effectiveness of Breast Cancer Prevention, Screening, and Treatment Interventions.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020Pooled it
- Assessing value in health care: using an interpretive classification system to understand existing practices based on a systematic review.BMC health services research · 2019Pooled it
- Pooled it
- A multiple criteria framework for value-based assessment of health care services applied to a radiology case.BMC health services research · 2025Article
- A Proposed Decision-Making Framework for the Translation of In-Person Clinical Care to Digital Care: Tutorial.JMIR medical education · 2024Article
- Healthcare Stakeholder Perspectives on a Value Assessment Approach for Duchenne Muscular Dystrophy Therapies.Journal of multidisciplinary healthcare · 2024Article
- Societal perspectives on disease and treatment attributes characterizing rare diseases: a qualitative study from the United States.Journal of patient-reported outcomes · 2022Article
- Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe.Journal of personalized medicine · 2022Article
- Evaluation frameworks for digital nursing technologies: analysis, assessment, and guidance. An overview of the literature.BMC nursing · 2021Article
- Profits, public health, and patient care: caring for childhood cancer survivors.Translational behavioral medicine · 2021Article
- Incorporating the Environmental Impact into a Budget Impact Analysis: The Example of Adopting RESPIMATApplied health economics and health policy · 2020Article
- A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMATAdvances in therapy · 2019Article
- Economic value of protected areas via visitor mental health.Nature communications · 2019Review
- Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer Patients.PharmacoEconomics · 2019Article
- Assessing the Joint Value of Genomic-Based Diagnostic Tests and Gene Therapies.Journal of personalized medicine · 2019Article
- Value-based medicine in oncology: the importance of perspective in the emerging value frameworks.Clinics (Sao Paulo, Brazil) · 2018Review
- Accelerating anticancer drug development - opportunities and trade-offs.Nature reviews. Clinical oncology · 2018Review
- Value assessment in oncology drugs: funding of drugs for metastatic breast cancer in Canada.Current oncology (Toronto, Ont.) · 2018Article
- Do current approaches to assessing therapy related adverse events align with the needs of long-term cancer patients and survivors?Cardio-oncology (London, England) · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 1 country.
Funding
Abstract
The recent acceleration of scientific discovery has led to greater choices in health care. New technologies, diagnostic tests, and pharmaceuticals have widely varying impact on patients and populations in terms of benefits, toxicities, and costs, stimulating a resurgence of interest in the creation of frameworks intended to measure value in health. Many of these are offered by providers and/or advocacy organizations with expertise and interest in specific diseases (e.g., cancer and heart disease). To help assess the utility of and the potential biases embedded in these frameworks, we created an evaluation taxonomy with seven basic components: 1) define the purpose; 2) detail the conceptual approach, including perspectives, methods for obtaining preferences of decision makers (e.g., patients), and ability to incorporate multiple dimensions of value; 3) discuss inclusions and exclusions of elements included in the framework, and whether the framework assumes clinical intervention or offers alternatives such as palliative care or watchful waiting; 4) evaluate data sources and their scientific validity; 5) assess the intervention's effect on total costs of treating a defined population; 6) analyze how uncertainty is incorporated; and 7) illuminate possible conflicts of interest among those creating the framework. We apply the taxonomy to four representative value frameworks recently published by professional organizations focused on treatment of cancer and heart disease and on vaccine use. We conclude that each of these efforts has strengths and weaknesses when evaluated using our taxonomy, and suggest pathways to enhance the utility of value-assessing frameworks for policy and clinical decision making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.